presymptomatic testing

presymptomatic testing

Molecular medicine The early testing of a Pt who may have–based on family Hx–a genetic disorder–eg, Huntington's disease or adult polycytic kidney disease, that manifests itself late in life. Cf Genotype.
Mentioned in ?
References in periodicals archive ?
This may present a better alternative to using CGG sizing as a first-line test in newborns or very young children, because detection of PM alleles that have been associated with late-onset disorders (30, 31) would raise the ethical issue of presymptomatic testing for currently untreatable and nonpreventable disorders with incomplete penetrance (32).
Quality in genetic counselling for presymptomatic testing clinical guidelines for practice across the range of genetic conditions.
Presymptomatic testing for adult-onset diseases in patients who have not yet reached the age of legal majority is generally not recommended because of the psychologic burden on the patient and may be prohibited by state or local laws.
1994, Timman, Maat-Kievit, Roos, & Tibben, 2004) have studied the psychological consequences of presymptomatic testing.
Presymptomatic testing of children (not recommended for individuals <18 years)
In spite of these insurance concerns, individuals may request genetic testing for a number of reasons including the determination of carrier status, preimplantation genetic diagnosis, prenatal diagnosis, newborn screening, presymptomatic testing for adult-onset disorders, diagnostic confirmation, and forensic identification.
Before the 21st century, predictive and presymptomatic testing for diseases that might manifest themselves later in life may become commonplace.
Three main types of genetic testing are available today: carrier testing, pre- and postnatal testing, and presymptomatic testing in the child or the adult.
With the exception of presymptomatic testing for familial polyposis coli [a genetic disorder resulting in colon cancer], there is no documented benefit to the child of testing for cystic fibrosis carrier status or presymptomatic testing for Huntington's disease.
As our understanding of underlying molecular mechanisms improves, identifying the molecular defects in the porphyria genes is becoming more successful, thereby enabling more families to benefit from presymptomatic testing.
Early Warning: Cases and Ethical Guidance for Presymptomatic Testing in Genetic Diseases.
The new marker will allow better presymptomatic testing for the disease.